Turçin Saridogan

442 total citations
10 papers, 102 citations indexed

About

Turçin Saridogan is a scholar working on Oncology, Pathology and Forensic Medicine and Cancer Research. According to data from OpenAlex, Turçin Saridogan has authored 10 papers receiving a total of 102 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 5 papers in Pathology and Forensic Medicine and 3 papers in Cancer Research. Recurrent topics in Turçin Saridogan's work include Genetic factors in colorectal cancer (5 papers), Colorectal Cancer Treatments and Studies (4 papers) and Cancer Genomics and Diagnostics (3 papers). Turçin Saridogan is often cited by papers focused on Genetic factors in colorectal cancer (5 papers), Colorectal Cancer Treatments and Studies (4 papers) and Cancer Genomics and Diagnostics (3 papers). Turçin Saridogan collaborates with scholars based in United States, Türkiye and South Korea. Turçin Saridogan's co-authors include İbrahim Halil Şahin, Erkan Yuca, Kurt W. Evans, Funda Meric‐Bernstam, Xiaofeng Zheng, Ming Zhao, Scott Kopetz, Sarina A. Piha‐Paul, Anwaar Saeed and Anil Korkut and has published in prestigious journals such as Scientific Reports, Clinical Cancer Research and The Cancer Journal.

In The Last Decade

Turçin Saridogan

8 papers receiving 100 citations

Peers

Turçin Saridogan
Joana L. Mora United States
Benjamin M. Kuter United States
Shaobu Weng United States
S. Lindsey Davis United States
Harry J. Han United States
Haitao Ma China
Turçin Saridogan
Citations per year, relative to Turçin Saridogan Turçin Saridogan (= 1×) peers J.J. Soto Castillo

Countries citing papers authored by Turçin Saridogan

Since Specialization
Citations

This map shows the geographic impact of Turçin Saridogan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Turçin Saridogan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Turçin Saridogan more than expected).

Fields of papers citing papers by Turçin Saridogan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Turçin Saridogan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Turçin Saridogan. The network helps show where Turçin Saridogan may publish in the future.

Co-authorship network of co-authors of Turçin Saridogan

This figure shows the co-authorship network connecting the top 25 collaborators of Turçin Saridogan. A scholar is included among the top collaborators of Turçin Saridogan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Turçin Saridogan. Turçin Saridogan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Saridogan, Turçin, Abigail E. Overacre-Delgoffe, Ronan W. Hsieh, et al.. (2025). Shedding Light on the Prognostic and Predictive Value of Circulating Tumor DNA for Management of Patients with Early-Stage Colon Cancer. Technology in Cancer Research & Treatment. 24. 2244058982–2244058982.
3.
Şahin, İbrahim Halil, Turçin Saridogan, Rüveyda Ayasun, et al.. (2024). Targeting KRAS Oncogene for Patients With Colorectal Cancer: A New Step Toward Precision Medicine. JCO Oncology Practice. 20(10). 1336–1347. 7 indexed citations
4.
Güven, Deniz Can, et al.. (2024). Investigating the WNT and TGF-beta pathways alterations and tumor mutation burden in young-onset colorectal cancer. Scientific Reports. 14(1). 17884–17884. 12 indexed citations
5.
Şahin, İbrahim Halil, et al.. (2024). The Role of Circulating Tumor DNA for Management of Patients With Rectal Cancer. The Cancer Journal. 30(4). 290–296. 1 indexed citations
6.
Şahin, İbrahim Halil, Janie Y. Zhang, Turçin Saridogan, et al.. (2023). Neoadjuvant Immune Checkpoint Inhibitor Therapy for Patients With Microsatellite Instability-High Colorectal Cancer: Shedding Light on the Future. JCO Oncology Practice. 19(5). 251–259. 17 indexed citations
7.
Duman, Duygu, Turçin Saridogan, Memoona Ramzan, et al.. (2023). Dispersed DNA variants underlie hearing loss in South Florida’s minority population. Human Genomics. 17(1). 103–103. 4 indexed citations
8.
Saridogan, Turçin, Argun Akçakanat, Ming Zhao, et al.. (2023). Efficacy of futibatinib, an irreversible fibroblast growth factor receptor inhibitor, in FGFR-altered breast cancer. Scientific Reports. 13(1). 20223–20223. 12 indexed citations
9.
Ayasun, Rüveyda, et al.. (2022). Systemic Therapy for Patients With Pancreatic Cancer: Current Approaches and Opportunities for Novel Avenues Toward Precision Medicine. Clinical Colorectal Cancer. 22(1). 2–11. 5 indexed citations
10.
Zhao, Ming, Kurt W. Evans, Erkan Yuca, et al.. (2021). Combining Neratinib with CDK4/6, mTOR, and MEK Inhibitors in Models of HER2-positive Cancer. Clinical Cancer Research. 27(6). 1681–1694. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026